Navigation Links
Stem cell cure for peripheral vascular disease: New hope on the horizon ,,

Peripheral Vascular Disease (PVD) is a near-pandemic condition that threatens millions with loss of limb, and also life. It is the build-up of atherosclerotic plaque in the arteries outside your heart.// Stem cell therapy enables patients’ own bodies to repair damaged blood vessels and grow new ones thus restoring blood flow and oxygen to damaged tissue.

TheraVitae, Ltd, a private, multinational company focuses on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has recently announced its intention to begin clinical trials using autologous adult stem cells to treat patients suffering from PVD. The trials are slated for November 2005 and will be held in conjunction with the Vascular Centers at both Chaophya Hospital and Bangkok Hospital. TheraVitae will supply its latest generation of Angiogenic Cell Precursors (ACPs) for the trials.

TheraVitae CEO Valentin Fulga envisions this new product going into mass-production along with its current product for heart disease, VesCell? in late 2006. “Our new manufacturing process will allow us to produce our autologous stem cell products at a cost that is much more competitive than other adult stem cell technologies such as bone marrow or cord blood. It will place stem cell therapy within the reach of the middle class”, he said.

The company expects this new treatment to create a revolution in vascular therapy; one that would save tens of thousands of limbs and ultimately, lives a year. This will not only save, but also return function to limbs that many people would have thought doomed to amputation


'"/>




Page: 1

Related medicine news :

1. Wake-up call for peripheral artery disease
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. High iron levels may cause Cardiovascular Disease in women
4. Erectile dysfunction (ED) signals vascular disease
5. Air Pollution said To Increase Risk of Cardiovascular Disease
6. Link Between Alcohol Consumption And Cardiovascular Disease
7. Beer Found To Be Effective In Fighting Cardiovascular Disease
8. New Guidelines Found To Benefit Cardiovascular Treatment
9. Women With A High-Risk Of Cardiovascular Disease Under treated
10. Diet and exercise to improve vascular function
11. People who fight wars may be at high risk of cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: